Literature DB >> 9511081

Cardiovascular alterations in septic shock.

J L Vincent1.   

Abstract

Cardiovascular alterations in sepsis include a decrease in vascular tone and an impairment in myocardial contractility, and occur largely as the result of the release and action of mediators of the sepsis cascade. Many mediators are involved including cytokines, particularly tumour necrosis factor and interleukin-1, and secondary mediators such as nitric oxide and oxygen free radicals. The degree of reduced vascular tone and myocardial depression have both been related to the severity of sepsis. In this article we will review current knowledge on the factors involved in the cardiovascular alterations of sepsis, the clinical implications of these alterations, and the possibilities for future treatments.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9511081     DOI: 10.1093/jac/41.suppl_1.9

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Presynaptic cannabinoid CB(1) receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats.

Authors:  Grzegorz Godlewski; Barbara Malinowska; Eberhard Schlicker
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

Review 2.  [Shock--what are the basics?].

Authors:  U Janssens; J Graf
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743

Review 3.  Pharmacological issues of linezolid: an updated critical review.

Authors:  Antonello Di Paolo; Paolo Malacarne; Emanuele Guidotti; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2010-07       Impact factor: 6.447

4.  Reinforcement therapy using nitric oxide synthase inhibitors against endotoxin shock in dogs.

Authors:  Hiroyasu Suga; Takao Nakagawa; Yukihiro Soga; Yoshizumi Deguchi; Tadashi Suzuki; Norio Miyoshi; Yoshiaki Imamura; Masaru Fukuda
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

5.  The nociceptin/orphanin FQ-NOP receptor antagonist effects on an animal model of sepsis.

Authors:  Dickson Carvalho; Fabricia Petronilho; Francieli Vuolo; Roberta Albino Machado; Larissa Constantino; Remo Guerrini; Girolamo Calo; Elaine Cristina Gavioli; Emílio Luiz Streck; Felipe Dal-Pizzol
Journal:  Intensive Care Med       Date:  2008-10-10       Impact factor: 17.440

6.  Characterization of human septic sera induced gene expression modulation in human myocytes.

Authors:  Shaimaa Hussein; Paul Michael; Danielle Brabant; Abdelwahab Omri; Ravin Narain; Kalpdrum Passi; Chilakamarti V Ramana; Joseph E Parrillo; Anand Kumar; Amadeo Parissenti; Aseem Kumar
Journal:  Int J Clin Exp Med       Date:  2009-06-05

7.  N-Ethylmaleimide Sensitive Factor (NSF) Inhibition Prevents Vascular Instability following Gram-Positive Pulmonary Challenge.

Authors:  Ji Young Lee; Helena M Linge; Kanta Ochani; Ke Lin; Edmund J Miller
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

8.  Platelet-derived exosomes from septic shock patients induce myocardial dysfunction.

Authors:  Luciano Cesar Pontes Azevedo; Mariano Janiszewski; Vera Pontieri; Marcelo de Almeida Pedro; Estevão Bassi; Paulo José Ferreira Tucci; Francisco Rafael Martins Laurindo
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.